SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device

Daniel Kim; Jeremy D. Collins; James A. White; Kate Hanneman; Daniel C. Lee; Amit R. Patel; Peng Hu; Harold Litt; Jonathan W. Weinsaft; Rachel Davids; Kanae Mukai; Ming Yen Ng; Julian A. Luetkens; Ariel Roguin; Carlos E. Rochitte; Pamela K. Woodard; Charlotte Manisty; Karolina M. Zareba; Lluis Mont; Frank Bogun; Daniel B. Ennis; Saman Nazarian; Gregory Webster; Jadranka Stojanovska

doi:10.1016/j.jocmr.2024.100995

SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device

Daniel Kim^*, Jeremy D. Collins, James A. White, Kate Hanneman, Daniel C. Lee, Amit R. Patel, Peng Hu, Harold Litt, Jonathan W. Weinsaft, Rachel Davids, Kanae Mukai, Ming Yen Ng, Julian A. Luetkens, Ariel Roguin, Carlos E. Rochitte, Pamela K. Woodard, Charlotte Manisty, Karolina M. Zareba, Lluis Mont, Frank BogunDaniel B. Ennis, Saman Nazarian, Gregory Webster, Jadranka Stojanovska

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Cardiovascular magnetic resonance (CMR) is a proven imaging modality for informing diagnosis and prognosis, guiding therapeutic decisions, and risk stratifying surgical intervention. Patients with a cardiac implantable electronic device (CIED) would be expected to derive particular benefit from CMR given high prevalence of cardiomyopathy and arrhythmia. While several guidelines have been published over the last 16 years, it is important to recognize that both the CIED and CMR technologies, as well as our knowledge in MR safety, have evolved rapidly during that period. Given increasing utilization of CIED over the past decades, there is an unmet need to establish a consensus statement that integrates latest evidence concerning MR safety and CIED and CMR technologies. While experienced centers currently perform CMR in CIED patients, broad availability of CMR in this population is lacking, partially due to limited availability of resources for programming devices and appropriate monitoring, but also related to knowledge gaps regarding the risk-benefit ratio of CMR in this growing population. To address the knowledge gaps, this SCMR Expert Consensus Statement integrates consensus guidelines, primary data, and opinions from experts across disparate fields towards the shared goal of informing evidenced-based decision-making regarding the risk-benefit ratio of CMR for patients with CIEDs.

Original language	English (US)
Article number	100995
Journal	Journal of Cardiovascular Magnetic Resonance
Volume	26
Issue number	1
DOIs	https://doi.org/10.1016/j.jocmr.2024.100995
State	Published - Jun 1 2024

Funding

We thank Dr. Joel Felmlee, PhD, for providing current and historical approaches to MRI of CIED patients at the Mayo Clinic. Drs. Kim and Lee were sponsored by funding from the National Institutes of Health (R01HL151079) that is directly related to this consensus statement. Besides Ms. Davids, none of the other authors have relationships with industry related to this consensus statement. Drs. Kim and Lee were sponsored by funding from the National Institutes of Health ( R01HL151079 ) that is directly related to this consensus statement. Besides Ms. Davids, none of the other authors have relationships with industry related to this consensus statement.

Keywords

Cardiac implantable electronic device
Cardiovascular magnetic resonance
Guidelines
MR safety

ASJC Scopus subject areas

Radiological and Ultrasound Technology
Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine
Family Practice

Access to Document

10.1016/j.jocmr.2024.100995

Cite this

Kim, D., Collins, J. D., White, J. A., Hanneman, K., Lee, D. C., Patel, A. R., Hu, P., Litt, H., Weinsaft, J. W., Davids, R., Mukai, K., Ng, M. Y., Luetkens, J. A., Roguin, A., Rochitte, C. E., Woodard, P. K., Manisty, C., Zareba, K. M., Mont, L., ... Stojanovska, J. (2024). SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device. Journal of Cardiovascular Magnetic Resonance, 26(1), Article 100995. https://doi.org/10.1016/j.jocmr.2024.100995

@article{123ec6ea37d6435bbadce845539c656a,

title = "SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device",

abstract = "Cardiovascular magnetic resonance (CMR) is a proven imaging modality for informing diagnosis and prognosis, guiding therapeutic decisions, and risk stratifying surgical intervention. Patients with a cardiac implantable electronic device (CIED) would be expected to derive particular benefit from CMR given high prevalence of cardiomyopathy and arrhythmia. While several guidelines have been published over the last 16 years, it is important to recognize that both the CIED and CMR technologies, as well as our knowledge in MR safety, have evolved rapidly during that period. Given increasing utilization of CIED over the past decades, there is an unmet need to establish a consensus statement that integrates latest evidence concerning MR safety and CIED and CMR technologies. While experienced centers currently perform CMR in CIED patients, broad availability of CMR in this population is lacking, partially due to limited availability of resources for programming devices and appropriate monitoring, but also related to knowledge gaps regarding the risk-benefit ratio of CMR in this growing population. To address the knowledge gaps, this SCMR Expert Consensus Statement integrates consensus guidelines, primary data, and opinions from experts across disparate fields towards the shared goal of informing evidenced-based decision-making regarding the risk-benefit ratio of CMR for patients with CIEDs.",

keywords = "Cardiac implantable electronic device, Cardiovascular magnetic resonance, Guidelines, MR safety",

author = "Daniel Kim and Collins, {Jeremy D.} and White, {James A.} and Kate Hanneman and Lee, {Daniel C.} and Patel, {Amit R.} and Peng Hu and Harold Litt and Weinsaft, {Jonathan W.} and Rachel Davids and Kanae Mukai and Ng, {Ming Yen} and Luetkens, {Julian A.} and Ariel Roguin and Rochitte, {Carlos E.} and Woodard, {Pamela K.} and Charlotte Manisty and Zareba, {Karolina M.} and Lluis Mont and Frank Bogun and Ennis, {Daniel B.} and Saman Nazarian and Gregory Webster and Jadranka Stojanovska",

note = "Publisher Copyright: {\textcopyright} 2024 The Authors",

year = "2024",

month = jun,

day = "1",

doi = "10.1016/j.jocmr.2024.100995",

language = "English (US)",

volume = "26",

journal = "Journal of Cardiovascular Magnetic Resonance",

issn = "1097-6647",

publisher = "BioMed Central",

number = "1",

}

Kim, D, Collins, JD, White, JA, Hanneman, K, Lee, DC, Patel, AR, Hu, P, Litt, H, Weinsaft, JW, Davids, R, Mukai, K, Ng, MY, Luetkens, JA, Roguin, A, Rochitte, CE, Woodard, PK, Manisty, C, Zareba, KM, Mont, L, Bogun, F, Ennis, DB, Nazarian, S, Webster, G & Stojanovska, J 2024, 'SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device', Journal of Cardiovascular Magnetic Resonance, vol. 26, no. 1, 100995. https://doi.org/10.1016/j.jocmr.2024.100995

TY - JOUR

T1 - SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device

AU - Kim, Daniel

AU - Collins, Jeremy D.

AU - White, James A.

AU - Hanneman, Kate

AU - Lee, Daniel C.

AU - Patel, Amit R.

AU - Hu, Peng

AU - Litt, Harold

AU - Weinsaft, Jonathan W.

AU - Davids, Rachel

AU - Mukai, Kanae

AU - Ng, Ming Yen

AU - Luetkens, Julian A.

AU - Roguin, Ariel

AU - Rochitte, Carlos E.

AU - Woodard, Pamela K.

AU - Manisty, Charlotte

AU - Zareba, Karolina M.

AU - Mont, Lluis

AU - Bogun, Frank

AU - Ennis, Daniel B.

AU - Nazarian, Saman

AU - Webster, Gregory

AU - Stojanovska, Jadranka

PY - 2024/6/1

Y1 - 2024/6/1

N2 - Cardiovascular magnetic resonance (CMR) is a proven imaging modality for informing diagnosis and prognosis, guiding therapeutic decisions, and risk stratifying surgical intervention. Patients with a cardiac implantable electronic device (CIED) would be expected to derive particular benefit from CMR given high prevalence of cardiomyopathy and arrhythmia. While several guidelines have been published over the last 16 years, it is important to recognize that both the CIED and CMR technologies, as well as our knowledge in MR safety, have evolved rapidly during that period. Given increasing utilization of CIED over the past decades, there is an unmet need to establish a consensus statement that integrates latest evidence concerning MR safety and CIED and CMR technologies. While experienced centers currently perform CMR in CIED patients, broad availability of CMR in this population is lacking, partially due to limited availability of resources for programming devices and appropriate monitoring, but also related to knowledge gaps regarding the risk-benefit ratio of CMR in this growing population. To address the knowledge gaps, this SCMR Expert Consensus Statement integrates consensus guidelines, primary data, and opinions from experts across disparate fields towards the shared goal of informing evidenced-based decision-making regarding the risk-benefit ratio of CMR for patients with CIEDs.

AB - Cardiovascular magnetic resonance (CMR) is a proven imaging modality for informing diagnosis and prognosis, guiding therapeutic decisions, and risk stratifying surgical intervention. Patients with a cardiac implantable electronic device (CIED) would be expected to derive particular benefit from CMR given high prevalence of cardiomyopathy and arrhythmia. While several guidelines have been published over the last 16 years, it is important to recognize that both the CIED and CMR technologies, as well as our knowledge in MR safety, have evolved rapidly during that period. Given increasing utilization of CIED over the past decades, there is an unmet need to establish a consensus statement that integrates latest evidence concerning MR safety and CIED and CMR technologies. While experienced centers currently perform CMR in CIED patients, broad availability of CMR in this population is lacking, partially due to limited availability of resources for programming devices and appropriate monitoring, but also related to knowledge gaps regarding the risk-benefit ratio of CMR in this growing population. To address the knowledge gaps, this SCMR Expert Consensus Statement integrates consensus guidelines, primary data, and opinions from experts across disparate fields towards the shared goal of informing evidenced-based decision-making regarding the risk-benefit ratio of CMR for patients with CIEDs.

KW - Cardiac implantable electronic device

KW - Cardiovascular magnetic resonance

KW - Guidelines

KW - MR safety

UR - http://www.scopus.com/inward/record.url?scp=85184882888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85184882888&partnerID=8YFLogxK

U2 - 10.1016/j.jocmr.2024.100995

DO - 10.1016/j.jocmr.2024.100995

M3 - Article

C2 - 38219955

AN - SCOPUS:85184882888

SN - 1097-6647

VL - 26

JO - Journal of Cardiovascular Magnetic Resonance

JF - Journal of Cardiovascular Magnetic Resonance

IS - 1

M1 - 100995

ER -

SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device

Abstract

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this